For research use only. Not for human or veterinary use. Product information is provided for laboratory research reference.
CJC-1295 + Ipamorelin
Pre-combined blend of a GHRH analogue (no DAC) and a selective ghrelin-receptor agonist in one research vial.
Description
This blend combines CJC-1295 (no DAC), a growth hormone–releasing hormone (GHRH) analogue, with Ipamorelin, a selective ghrelin-receptor agonist, 1:1 by mass in a single vial. The two act on separate, complementary pathways of growth hormone release.
Research focus
- Growth hormone axis research using paired GHRH and ghrelin-receptor pathways
- Pulsatile growth hormone release studies
- Simplified handling for paired-compound protocols
Supplied as a lyophilised powder in a sealed vial. Available in 5 mg + 5 mg and 10 mg + 10 mg strengths.
Each batch is independently tested, and the certificate of analysis matching the lot number on your vial is published on our COA page.
For laboratory research use only. Not for human or veterinary use.
- Same-day dispatch on business days Order before 2:00 pm AEDT on business days
- Free express shipping over $150 Tracked delivery Australia-wide
- Protected, discreet packaging Every vial cushioned and sealed
- Certificate for every batch Lot-matched, independently tested
Technical specifications
Compound information
Molecular profile
What is CJC-1295 + Ipamorelin?
This blend combines CJC-1295 (no DAC), a growth hormone–releasing hormone (GHRH) analogue, with Ipamorelin, a selective ghrelin-receptor agonist, 1:1 by mass in a single vial. The two act on separate, complementary pathways of growth hormone release.
Research focus
- Growth hormone axis research using paired GHRH and ghrelin-receptor pathways
- Pulsatile growth hormone release studies
- Simplified handling for paired-compound protocols
Supplied as a lyophilised powder in a sealed vial. Available in 5 mg + 5 mg and 10 mg + 10 mg strengths.
Each batch is independently tested, and the certificate of analysis matching the lot number on your vial is published on our COA page.
For laboratory research use only. Not for human or veterinary use.
- Type
- Peptide blend (GHRH analogue + ghrelin-receptor agonist)
- CJC-1295 (no DAC) CAS
- 863288-34-0
- Ipamorelin CAS
- 170851-70-4
- Ratio
- 1 : 1 by mass
Storage requirements
Stability information
- Lyophilised (sealed vial)−20 °C long-term, protected from light
- Reconstituted2–8 °C, use within 28 days
- In transitStable at ambient temperature for shipping
Product details
- Strength
- 5mg/5mg, 10mg/10mg
- Purity
- ≥99% (HPLC)
- Form
- Lyophilised powder
- Category
- New Arrivals, Peptide Blends




